Intervention pilot trial for suppression of colibactin-producing E. coli implicated in colorectal carcinogenesis
Ontology highlight
ABSTRACT: Interventions: Colibactin positive patients are given biolactis (3 g/day) for 3 months.
Primary outcome(s): Detection of colibactin-producing bacteria 90 days after the start of the intervention.
Study Design: single arm study, open(masking not used), no treatment control/standard of care control, single assignment, basic science
DISEASE(S): Colorectal Neoplasia(endoscopically Removed),Colon Tumor
PROVIDER: 2615357 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA